Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis

Lewis JT, Hartmann LC, Vierkant RA, Maloney SD, Shane Pankratz V, Allers TM, et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol. 2006;30(6):665–72.

Article  Google Scholar 

Esmayil H, Abayazeed S, Hajaj M. Audit on intraductal papilloma of the breast: upgrade rate, management pitfalls, and updated guidelines in a Tertiary Health Care Center. Cureus. 2021;13(10): e18763.

PubMed  PubMed Central  Google Scholar 

Ni YB, Tse GM. Pathological criteria and practical issues in papillary lesions of the breast—A review. Histopathology. 2016;68(1):22–32.

Article  Google Scholar 

Kraus FT, Neubecker RD. The differential diagnosis of papillary tumors of the breast. Cancer. 1962;15:444–55.

CAS  Article  Google Scholar 

Kulka J, Madaras L, Floris G, Lax SF. Papillary lesions of the breast. Virchows Arch. 2021;480:65.

Article  Google Scholar 

Moynihan A, Quinn EM, Smith CS, Stokes M, Kell M, Barry JM, et al. Benign breast papilloma: Is surgical excision necessary? Breast J. 2020;26(4):705–10.

Article  Google Scholar 

Abbassi-Rahbar S, Sack S, Larson KE, Wagner JL, Kilgore LJ, Balanoff CR, et al. Multidisciplinary review of intraductal papilloma of the breast can identify patients who may omit surgical excision. Ann Surg Oncol. 2021;28(10):5768–74.

Article  Google Scholar 

Lee SJ, Wahab RA, Sobel LD, Zhang B, Brown AL, Lewis K, et al. Analysis of 612 benign papillomas diagnosed at core biopsy: rate of upgrade to malignancy, factors associated with upgrade, and a proposal for selective surgical excision. AJR Am J Roentgenol. 2021;217(6):1299–311.

Article  Google Scholar 

Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353(3):229–37.

CAS  Article  Google Scholar 

Ibarra JA. Papillary lesions of the breast. Breast J. 2006;12(3):237–51.

Article  Google Scholar 

Kader T, Elder K, Zethoven M, Semple T, Hill P, Goode DL, et al. The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma. NPJ Breast Cancer. 2020;6:9.

CAS  Article  Google Scholar 

Ahmadiyeh N, Stoleru MA, Raza S, Lester SC, Golshan M. Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome. Ann Surg Oncol. 2009;16(8):2264–9.

Article  Google Scholar 

Zhang X, Liu W, Hai T, Li F. Upgrade rate and predictive factors for breast benign intraductal papilloma diagnosed at biopsy: a meta-analysis. Ann Surg Oncol. 2021;28(13):8643–50.

Article  Google Scholar 

Qiu L, Mais DD, Nicolas M, Nanyes J, Kist K, Nazarullah A. Diagnosis of papillary breast lesions on core needle biopsy: upgrade rates and interobserver variability. Int J Surg Pathol. 2019;27(7):736–43.

Article  Google Scholar 

Weber GF, Lett GS, Haubein NC. Osteopontin is a marker for cancer aggressiveness and patient survival. Br J Cancer. 2010;103(6):861–9.

CAS  Article  Google Scholar 

Weber GF, Lett GS, Haubein NC. Categorical meta-analysis of Osteopontin as a clinical cancer marker. Oncol Rep. 2011;25(2):433–41.

Article  Google Scholar 

Walaszek K, Lower EE, Ziolkowski P, Weber GF. Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis. Br J Cancer. 2018;119(10):1259–66.

CAS  Article  Google Scholar 

Mirza M, Shaughnessy E, Hurley JK, Vanpatten KA, Pestano GA, He B, et al. Osteopontin-c is a selective marker of breast cancer. Int J Cancer. 2008;122(4):889–97.

CAS  Article  Google Scholar 

Zduniak K, Ziolkowski P, Ahlin C, Agrawal A, Agrawal S, Blomqvist C, et al. Nuclear osteopontin-c is a prognostic breast cancer marker. Br J Cancer. 2015;112(4):729–38.

CAS  Article  Google Scholar 

Zduniak K, Agrawal A, Agrawal S, Hossain MM, Ziolkowski P, Weber GF. Osteopontin splice variants are differential predictors of breast cancer treatment responses. BMC Cancer. 2016;16:441.

Article  Google Scholar 

Pang H, Lu H, Song H, Meng Q, Zhao Y, Liu N, et al. Prognostic values of osteopontin-c, E-cadherin and beta-catenin in breast cancer. Cancer Epidemiol. 2013;37(6):985–92.

Article  Google Scholar 

Zhang MX, Xu YJ, Zhu MC, Yan F. Overexpressed ostepontin-c as a potential biomarker for esophageal squamous cell carcinoma. Asian Pac J Cancer Prev. 2013;14(12):7315–9.

Article  Google Scholar 

Tilli TM, Thuler LC, Matos AR, Coutinho-Camillo CM, Soares FA, da Silva EA, et al. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia. Exp Mol Pathol. 2012;92(1):13–9.

CAS  Article  Google Scholar 

Sakr R, Rouzier R, Salem C, Antoine M, Chopier J, Darai E, et al. Risk of breast cancer associated with papilloma. Eur J Surg Oncol. 2008;34(12):1304–8.

CAS  Article  Google Scholar 

Limberg J, Kucher W, Fasano G, Hoda S, Michaels A, Marti JL. Intraductal papilloma of the breast: prevalence of malignancy and natural history under active surveillance. Ann Surg Oncol. 2021;28(11):6032–40.

Article  Google Scholar 

Crosby D, Bhatia S, Brindle KM, Coussens LM, Dive C, Emberton M, et al. Early detection of cancer. Science. 2022;375(6586):eaay9040.

Anborgh PH, Wilson SM, Tuck AB, Winquist E, Schmidt N, Hart R, et al. New dual monoclonal ELISA for measuring plasma osteopontin as a biomarker associated with survival in prostate cancer: clinical validation and comparison of multiple ELISAs. Clin Chem. 2009;55(5):895–903.

CAS  Article  Google Scholar 

Krishnamurthy S, Sneige N. Molecular and biologic markers of premalignant lesions of human breast. Adv Anat Pathol. 2002;9(3):185–97.

Article  Google Scholar 

Stark A, Hulka BS, Joens S, Novotny D, Thor AD, Wold LE, et al. HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer. J Clin Oncol. 2000;18(2):267–74.

CAS  Article  Google Scholar 

Ramchandani D, Weber GF. An osteopontin promoter polymorphism is associated with aggressiveness in breast cancer. Oncol Rep. 2013;30(4):1860–8.

CAS  Article  Google Scholar 

He B, Mirza M, Weber GF. An osteopontin splice variant induces anchorage independence in human breast cancer cells. Oncogene. 2006;25(15):2192–202.

CAS  Article  Google Scholar 

Shen H, Weber GF. The osteopontin-c splice junction is important for anchorage-independent growth. Mol Carcinog. 2014;53(6):480–7.

CAS  Article  Google Scholar 

留言 (0)

沒有登入
gif